| Characteristic | Description |
|---|---|
| Active Ingredients | Sildenafil 100mg, Vardenafil 20mg |
| Dosage Form | Tablet |
| Administration Route | Oral |
| Indications | Erectile Dysfunction |
| Storage Conditions | Store in a cool, dry place below 25°C |
| Side Effects | Headache, Flushing, Dizziness |
| Visit Silvitra Website | |
Pharmacokinetics of Silvitra
Silvitra tablets contain Sildenafil 100mg and Vardenafil 20mg. These compounds influence pharmacokinetic profiles. Sildenafil is absorbed rapidly. Peak plasma levels occur within 30 to 120 minutes. The half-life spans approximately 4 hours. Vardenafil, however, peaks in the plasma around 60 minutes post-ingestion. Its half-life is approximately 4 to 5 hours. Both substances bind to plasma proteins by over 95%. Metabolism occurs predominantly in the liver, mediated by cytochrome P450 enzymes.
Excretion of both active ingredients occurs mainly in the feces, with a smaller percentage in the urine. Both sildenafil and vardenafil are cleared similarly. Their elimination ensures that active compounds do not accumulate in significant amounts, even with regular dosing.
Mechanism of Action
Silvitra’s potency arises from its dual-action mechanism. Sildenafil and Vardenafil are phosphodiesterase type 5 inhibitors. Inhibition of PDE5 increases cyclic guanosine monophosphate (cGMP) levels in the corpus cavernosum. This leads to smooth muscle relaxation and enhanced blood flow. Thus, erectile response to sexual stimulation is improved.
Unlike other agents, Silvitra employs a synergistic approach. Both active agents enhance nitric oxide-mediated vasodilation. This robust mechanism results in more effective and longer-lasting effects compared to monotherapies.
FDA-Approved Indications
Silvitra is sanctioned for the treatment of erectile dysfunction. FDA approval underscores its safety and efficacy for this condition. The combination of Sildenafil 100mg and Vardenafil 20mg addresses a broad spectrum of erectile dysfunction. Enhanced patient satisfaction stems from this dual-action formulation.
Healthcare providers may consider Silvitra for patients unresponsive to monotherapy. Its efficacy has been confirmed in numerous clinical trials. Patients report significant improvement in erectile function and overall sexual satisfaction.
Silvitra Storage
Proper storage of Silvitra is essential. Keep tablets in their original packaging until use. Store at temperatures below 25°C, away from moisture. Protect from direct light exposure. Ensure that medications are out of children’s reach.
Storage conditions impact drug stability. Deviations from recommended settings may reduce efficacy. Follow storage guidelines to maintain Silvitra’s therapeutic benefits.
Silvitra Side Effects
Like any medication, Silvitra may cause adverse effects. Commonly reported ones include headache, flushing, and dizziness. Some patients experience nasal congestion or dyspepsia. These effects are generally mild and transient.
More serious side effects, although rare, may include vision changes or priapism. Immediate medical attention is necessary if severe reactions occur. Report any persistent or troublesome symptoms to healthcare providers.
Purchasing Silvitra Without a Prescription
Obtaining Silvitra without a prescription carries risks. Regulations require a valid prescription for dispensation. Unsupervised use may lead to adverse outcomes.
Ensure to consult with healthcare professionals prior to use. Prescriptions enable appropriate dosing and monitoring. Legitimate purchase routes ensure the authenticity and safety of the medication. Adherence to legal and medical guidance is imperative for patient safety.
- Pharmacokinetics involve rapid absorption and elimination.
- Sildenafil and Vardenafil work synergistically for ED.
- Store Silvitra below 25°C, away from light and moisture.
- Seek medical advice before obtaining Silvitra.
Silvitra presents a unique solution for erectile dysfunction with its dual-action formula. Adhering to guidelines ensures optimal results and patient safety.
